Literature DB >> 18210020

[Therapy of chronic stable angina].

U Sechtem1.   

Abstract

Chronic stable angina is a common clinical problem limiting the quality of life. Patients with suspected stable angina require prompt cardiological investigation to ensure that the diagnosis is correct and that the prognosis is evaluated. An initial non-invasive strategy using an exercise test is most appropriate. All patients should be advised regarding life-style modifications to correct risk factors. In the absence of contraindications or intolerance acetylsalicylic acid and statins should be given. ACE-inhibitors are indicated in patients with left ventricular dysfunction, hypertension or diabetes and patients with other high-risk features. Beta blockers are used in all patients after myocardial infarction and those with left ventricular dysfunction. Anti-anginal therapy is based on the use of short-acting nitrates. Beta blockers, calcium antagonists and long-acting nitrates reduce the frequency and intensity of angina. In patients with high-risk features and those whose symptoms cannot be adequately controlled by medications coronary angiography should be considered. Both percutaneous coronary intervention and coronary artery bypass graft operation (CABG) are effective measures to control anginal symptoms. However, only CABG has been shown to improve prognosis in some high-risk patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18210020     DOI: 10.1007/s00108-007-2006-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  16 in total

1.  Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization.

Authors:  R F Davies; A D Goldberg; S Forman; C J Pepine; G L Knatterud; N Geller; G Sopko; C Pratt; J Deanfield; C R Conti
Journal:  Circulation       Date:  1997-04-15       Impact factor: 29.690

2.  The use of nonsteroidal anti-inflammatory drugs (NSAIDs): a science advisory from the American Heart Association.

Authors:  Joel S Bennett; Alan Daugherty; David Herrington; Philip Greenland; Harold Roberts; Kathryn A Taubert
Journal:  Circulation       Date:  2005-03-21       Impact factor: 29.690

3.  Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.

Authors:  F Catella-Lawson; M P Reilly; S C Kapoor; A J Cucchiara; S DeMarco; B Tournier; S N Vyas; G A FitzGerald
Journal:  N Engl J Med       Date:  2001-12-20       Impact factor: 91.245

4.  Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials.

Authors:  H C Bucher; P Hengstler; C Schindler; G H Guyatt
Journal:  BMJ       Date:  2000-07-08

5.  Angiotensin-converting-enzyme inhibition in stable coronary artery disease.

Authors:  Eugene Braunwald; Michael J Domanski; Sarah E Fowler; Nancy L Geller; Bernard J Gersh; Judith Hsia; Marc A Pfeffer; Madeline M Rice; Yves D Rosenberg; Jean L Rouleau
Journal:  N Engl J Med       Date:  2004-11-07       Impact factor: 91.245

6.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

7.  Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial.

Authors: 
Journal:  Lancet       Date:  2002-04-13       Impact factor: 79.321

8.  Intensive lipid lowering with atorvastatin in patients with stable coronary disease.

Authors:  John C LaRosa; Scott M Grundy; David D Waters; Charles Shear; Philip Barter; Jean-Charles Fruchart; Antonio M Gotto; Heiner Greten; John J P Kastelein; James Shepherd; Nanette K Wenger
Journal:  N Engl J Med       Date:  2005-03-08       Impact factor: 91.245

9.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

Authors:  Guy De Backer; Ettore Ambrosioni; Knut Borch-Johnsen; Carlos Brotons; Renata Cifkova; Jean Dallongeville; Shah Ebrahim; Ole Faergeman; Ian Graham; Giuseppe Mancia; Volkert Manger Cats; Kristina Orth-Gomér; Joep Perk; Kalevi Pyörälä; José L Rodicio; Susana Sans; Vedat Sansoy; Udo Sechtem; Sigmund Silber; Troels Thomsen; David Wood
Journal:  Eur Heart J       Date:  2003-09       Impact factor: 29.983

10.  Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration.

Authors:  S Yusuf; D Zucker; P Peduzzi; L D Fisher; T Takaro; J W Kennedy; K Davis; T Killip; E Passamani; R Norris
Journal:  Lancet       Date:  1994-08-27       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.